Lauren L Todd, Ram Sivakumar, Sharon G Lynch, Jennifer H Diebolt, Jacob White, Jennifer A Villwock
{"title":"Longitudinal Olfactory Patterns in Multiple Sclerosis: A Scoping Review and Implication for Use in Management of Disease.","authors":"Lauren L Todd, Ram Sivakumar, Sharon G Lynch, Jennifer H Diebolt, Jacob White, Jennifer A Villwock","doi":"10.7224/1537-2073.2022-019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although studies regarding multiple sclerosis (MS) and olfactory dysfunction (OD) have been previously described and summarized, there is not a sole review of longitudinal studies regarding the matter. This review examines the existing literature investigating MS and its effect on olfaction. In addition, the role of OD in the diagnosis and prognosis of MS is explored.</p><p><strong>Methods: </strong>A scoping review of the literature was performed covering longitudinal studies investigating MS and OD. Systematic searches of PubMed, Google Scholar, Web of Science, Embase, PsycInfo, Cumulative Index to Nursing and Allied Health Literature, AgeLine, and MEDLINE were performed using terms that encompassed MS and olfaction. The aim of this review was to build on the existing literature by summarizing only findings that were demonstrated longitudinally.</p><p><strong>Results: </strong>Of 6938 articles identified from the search, 9 met the inclusion criteria: longitudinal observation of relapsing-remitting or progressive MS. Olfaction was measured and scored using various testing arrays, and these scores were then correlated with a multitude of clinical markers. Across all studies, patients with MS demonstrated increased OD. Longitudinally, 2 contrasting patterns were identified: (1) clinical markers of acute inflammation correlated with an increased odor threshold and (2) clinical markers of neurodegeneration, or progression of disease, correlated with a decreased ability to discriminate and identify odors.</p><p><strong>Conclusions: </strong>These studies suggest that olfaction is a dynamic, dependent variable of neurodegeneration, correlating with inflammation and clinical markers. This opens the door for future exploration of olfaction's relationship with MS diagnosis, characterization, and therapeutic response.</p>","PeriodicalId":14150,"journal":{"name":"International journal of MS care","volume":"25 3","pages":"131-136"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211351/pdf/i1537-2073-25-3-131.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of MS care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7224/1537-2073.2022-019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Although studies regarding multiple sclerosis (MS) and olfactory dysfunction (OD) have been previously described and summarized, there is not a sole review of longitudinal studies regarding the matter. This review examines the existing literature investigating MS and its effect on olfaction. In addition, the role of OD in the diagnosis and prognosis of MS is explored.
Methods: A scoping review of the literature was performed covering longitudinal studies investigating MS and OD. Systematic searches of PubMed, Google Scholar, Web of Science, Embase, PsycInfo, Cumulative Index to Nursing and Allied Health Literature, AgeLine, and MEDLINE were performed using terms that encompassed MS and olfaction. The aim of this review was to build on the existing literature by summarizing only findings that were demonstrated longitudinally.
Results: Of 6938 articles identified from the search, 9 met the inclusion criteria: longitudinal observation of relapsing-remitting or progressive MS. Olfaction was measured and scored using various testing arrays, and these scores were then correlated with a multitude of clinical markers. Across all studies, patients with MS demonstrated increased OD. Longitudinally, 2 contrasting patterns were identified: (1) clinical markers of acute inflammation correlated with an increased odor threshold and (2) clinical markers of neurodegeneration, or progression of disease, correlated with a decreased ability to discriminate and identify odors.
Conclusions: These studies suggest that olfaction is a dynamic, dependent variable of neurodegeneration, correlating with inflammation and clinical markers. This opens the door for future exploration of olfaction's relationship with MS diagnosis, characterization, and therapeutic response.
背景:尽管先前已经对多发性硬化症(MS)和嗅觉功能障碍(OD)的研究进行了描述和总结,但对这一问题的纵向研究并没有唯一的综述。这篇综述审查了研究MS及其对嗅觉影响的现有文献。此外,还探讨了OD在MS诊断和预后中的作用。方法:对研究MS和OD的纵向研究的文献进行范围审查。使用包括MS和嗅觉的术语对PubMed、Google Scholar、Web of Science、Embase、PsycInfo、护理和相关健康文献累积索引、AgeLine和MEDLINE进行系统搜索。这篇综述的目的是在现有文献的基础上,只总结纵向证明的发现。结果:在检索到的6938篇文章中,有9篇符合纳入标准:对复发-缓解或进行性多发性硬化症的纵向观察。使用各种测试阵列对嗅觉进行测量和评分,然后将这些评分与多种临床标志物相关联。在所有研究中,多发性硬化症患者的OD增加。从纵向上看,确定了两种对比模式:(1)急性炎症的临床标志物与气味阈值增加相关,(2)神经退行性变或疾病进展的临床标志性与辨别和识别气味的能力下降相关。结论:这些研究表明嗅觉是神经退行性变的一个动态因变量,与炎症和临床标志物相关。这为未来探索嗅觉与MS诊断、表征和治疗反应的关系打开了大门。